PP60SRC BINDING PROTEIN AFAP-110
PP60SRC BINDING PROTEIN AFAP-110
批准号:
2101486
负责人:
Daniel Charles Flynn
金额:
$10.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-05-01 至 1999-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SH2 and SH3 domains represent important cell signalling motifs that are
conserved among a number of kinases known to mediate mitogenesis and
transformation. SH2 domains function by interacting with phosphotyrosine
containing substrates, while SH3 domains are hypothesized to link
proteins to either cytoskeletal structures and/or ras signaling pathways.
The integrity of the SH2 and SH3 domains of the nonreceptor tyrosine
kinase pp60 (Src) are critical for mediating transformation. These
domains are likely to be important to be important for mediating pp60
signaling processes, as well. Therefore, the identity of cellular
proteins that interact with the SH2 and/or SH3 domains of pp60 will
likely represent important components in signal transduction and
transformation. In this proposal, the mechanism by which the novel pp60
binding protein, AFAP-110 (for Actin Filament Associated Protein, 110
kDa) forms a stable complex with pp60 will be examined. AFAP-110 can
independently form a stable interaction with either the Src or Fyn SH2
and SH3 domains. AFAP-110 does encode peptide motifs that represent
consensus Sr SH2 and SH3 binding motifs, thus AFAP-110 is distinctive in
that it represents both an SH2 and SH3 binding protein. Identification
of these motifs will be accomplished by introducing mutations that
abrogate SH2 or SH3 mediated interactions. A hypothesis will be tested
that indicates the mechanism of stable complex formation between AFAP-110
and pp60 occurs by a two-step binding process, governed by a primary SH43
mediated interaction, followed by tyrosine phosphorylation and SH2
mediated stable complex formation. The potential role of AFAP-110 in
modulating transformation will be examined by competitively disrupting
the pp60. AFAP-110 stable complex, in vivo. AFAP-110 will also serve
as a model for "peptide mimetics", whereby the SH2 and/or SH3 binding
motifs will be overexpressed in cells susceptible to transformation by
Src. In this way, the SH2 and/or SH3 domains would be blocked from
interactions with cellular substrates. Should this interruption effect
the transformed phenotype, then this technique could be applied to human
cancer cell lines that express activated tyrosine kinases, to determine
the role of those kinases in effecting phenotype.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COBRE: WVU: SIGNAL TRANSDUCTION & CANCER: ADMINISTRATIVE CORE
-
批准号:7720590
-
项目类别:
-
资助金额:$32.37万
-
财政年份:2008
-
负责人:Daniel Charles Flynn
-
依托单位:
COBRE: WVU: SIGNAL TRANSDUCTION & CANCER: ADMINISTRATIVE CORE
-
批准号:7609882
-
项目类别:
-
资助金额:$33.03万
-
财政年份:2007
-
负责人:Daniel Charles Flynn
-
依托单位:
COBRE: WVU: SIGNAL TRANSDUCTION & CANCER: ADMINISTRATIVE CORE
-
批准号:7381270
-
项目类别:
-
资助金额:$34.02万
-
财政年份:2006
-
负责人:Daniel Charles Flynn
-
依托单位:
COBRE: WVU: SIGNAL TRANSDUCTION & CANCER: ADMINISTRATIVE CORE
-
批准号:7170504
-
项目类别:
-
资助金额:$42.24万
-
财政年份:2005
-
负责人:Daniel Charles Flynn
-
依托单位:
COBRE FOR SIGNAL TRANSDUCTION AND CANCER
-
批准号:6411801
-
项目类别:
-
资助金额:$213.87万
-
财政年份:2001
-
负责人:Daniel Charles Flynn
-
依托单位:
Cobre for Signal Transduction and Cancer
-
批准号:7134412
-
项目类别:
-
资助金额:$219.08万
-
财政年份:2001
-
负责人:Daniel Charles Flynn
-
依托单位:
COBRE FOR SIGNAL TRANSDUCTION AND CANCER
-
批准号:6796418
-
项目类别:
-
资助金额:$218.08万
-
财政年份:2001
-
负责人:Daniel Charles Flynn
-
依托单位:
Cobre for Signal Transduction and Cancer
-
批准号:7284185
-
项目类别:
-
资助金额:$212.73万
-
财政年份:2001
-
负责人:Daniel Charles Flynn
-
依托单位:
COBRE FOR SIGNAL TRANSDUCTION AND CANCER
-
批准号:6530184
-
项目类别:
-
资助金额:$218.5万
-
财政年份:2001
-
负责人:Daniel Charles Flynn
-
依托单位:
COBRE FOR SIGNAL TRANSDUCTION AND CANCER
-
批准号:6637379
-
项目类别:
-
资助金额:$218.03万
-
财政年份:2001
-
负责人:Daniel Charles Flynn
-
依托单位:
Supplement for Cobre in Signal Transduction and Cancer R
-
批准号:6710244
-
项目类别:
-
资助金额:$35.18万
-
财政年份:2001
-
负责人:Daniel Charles Flynn
-
依托单位:
COBRE FOR SIGNAL TRANSDUCTION AND CANCER
-
批准号:6922887
-
项目类别:
-
资助金额:$218.08万
-
财政年份:2001
-
负责人:Daniel Charles Flynn
-
依托单位:
AFAP 110 MODULATES SIGNALS THAT EFFECT ACTIN FILAMENTS
-
批准号:2902197
-
项目类别:
-
资助金额:$22.79万
-
财政年份:1994
-
负责人:Daniel Charles Flynn
-
依托单位:
AFAP-110 regulates signals that affect F-actin
-
批准号:6888974
-
项目类别:
-
资助金额:$26.85万
-
财政年份:1994
-
负责人:Daniel Charles Flynn
-
依托单位:
AFAP-110 as a cSrc activator in breast cancer
-
批准号:8193181
-
项目类别:
-
资助金额:$22.9万
-
财政年份:1994
-
负责人:Daniel Charles Flynn
-
依托单位:
AFAP-110 regulates signals that affect F-actin
-
批准号:7064190
-
项目类别:
-
资助金额:$3.75万
-
财政年份:1994
-
负责人:Daniel Charles Flynn
-
依托单位:
AFAP 110 MODULATES SIGNALS THAT EFFECT ACTIN FILAMENTS
-
批准号:6787336
-
项目类别:
-
资助金额:$8.73万
-
财政年份:1994
-
负责人:Daniel Charles Flynn
-
依托单位:
AFAP 110 MODULATES SIGNALS THAT EFFECT ACTIN FILAMENTS
-
批准号:6512975
-
项目类别:
-
资助金额:$26.4万
-
财政年份:1994
-
负责人:Daniel Charles Flynn
-
依托单位:
AFAP-110 as a cSrc activator in breast cancer
-
批准号:7740622
-
项目类别:
-
资助金额:$24.63万
-
财政年份:1994
-
负责人:Daniel Charles Flynn
-
依托单位:
AFAP-110 regulates signals that affect F-actin
-
批准号:7333090
-
项目类别:
-
资助金额:$3.83万
-
财政年份:1994
-
负责人:Daniel Charles Flynn
-
依托单位:
海外基金